Core Viewpoint - The company "Shuangfeiren" has initiated an IPO counseling period from April 1, 2025, to June 30, 2025, and is recognized as a national high-tech enterprise specializing in the research, production, and sales of pharmaceuticals, cosmetics, health products, and disinfectants [2]. Group 1: Company Overview - "Shuangfeiren" has a strong brand presence in South China, with its product series being well-known in the region [2]. - The company collaborates with mainstream distributors in various regions, distributing products to over 80,000 terminal customers, including large chain pharmacies, brand supermarkets, convenience stores, and maternal and infant stores [2]. Group 2: Financial Performance - In the first half of 2025, "Shuangfeiren" reported a revenue of 21.39 million yuan, a decrease from 23.34 million yuan in the same period last year [3]. - The company's gross profit margin improved to 82.45%, up from 79.08% year-on-year [3]. - The net profit attributable to shareholders was -252,924.86 yuan, compared to a profit of 5,251,456.42 yuan in the previous year [3].